Attached files

file filename
EX-16.1 - EXHIBIT 16.1 LETTER FROM KR MARGETSON, LTD., CPA - MARIZYME INCf8k091820_ex16z1.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 18, 2020 (September 15, 2020)

 

MARIZYME, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

000-27237

 

82-5464863

(State or other jurisdiction

of incorporation)

 

(Commission File Number)

 

(IRS Employer

Identification No.)

 

225 Chimney Corner Lane, Suite 2001, Jupiter, Florida

 

33458

(Address of principal executive offices)

 

(Zip Code)

 

(732) 723-7395

(Registrant’s telephone number, including area code)

 

109 Ambersweet Way, #401 Davenport, Florida 33897

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

 

[   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

 

[   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

 

[   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging Growth Company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

[   ]

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Not applicable.

 

 

 


 

 

Item 4.01Changes in Registrant’s Certifying Accountant  

 

Marizyme, Inc. (the “Company”) has dismissed KR Margetson, Ltd., CPA (the “Former Accounting Firm”) as its independent registered public accounting firm, effective as of September 15, 2020. As described in Item 4.01(a) below, the change in independent registered public accounting firm is not the result of any disagreement with the Former Accounting Firm.

 

Item 4.01(a)Previous Independent Accountants  

 

(i) On September 15, 2020, the Company dismissed the Former Accounting Firm as its independent registered public accounting firm effective on that date.

 

(ii) The Former Accounting Firm of the Company's financial statements has not issued an adverse opinion or disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope, or accounting principles up to and including September 15, 2020.

 

(iii) The reports of the Former Accounting Firm on the Company’s financial statements as of and for the year ended December 31, 2019 contained an explanatory paragraph which noted that there was substantial doubt as to the Company’s ability to continue as a going concern as the Company has incurred net losses since inception and existing uncertain conditions which the Company faces relative to its obtaining capital in the equity markets.

 

(v) The Company’s Board made the decision to change independent accountants, acting under authority delegated to it, and approved the change of the independent accountants at a Board of Director’s meeting on September 15, 2020.

 

(iv) During the period through September 15, 2020, there (i) have been no disagreements with the Former Accounting Firm on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of the Former Accounting Firm, would have caused the Former Accounting Firm to make reference to the subject matter of such disagreements in its reports on the financial statements for such years and (ii) were no reportable events of the kind in Item 304(a)(1)(v) of Regulation S-K.

 

The Company has requested that the Former Accounting Firm furnish it with a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the above statement. A copy of the letter from the Former Accounting Firm is attached hereto as Exhibit 16.1 to this Form 8-K.

 

Item 4.01(b)New Independent Accountants  

 

On September 15, 2020, the Company engaged WithumSmith+Brown, PC (the “New Accounting Firm”) as our independent registered public accounting firm for the year ended December 31, 2020. The Board made the decision to engage the New Accounting Firm acting under authority delegated to it and the Board of Directors approved the same on September 15, 2020.

 

The Company has not consulted with the New Accounting Firm during our two most recent fiscal years or during any subsequent interim period prior to its appointment as New Accounting Firm regarding either (i) the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on our financial statements, and neither a written report was provided to us nor oral advice was provided that the New Accounting Firm concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was either the subject of disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) or a reportable event (within the meaning of Item 304(a)(1)(v) of Regulation S-K).

 

Exhibits

 

16.1Letter from KR Margetson, Ltd., CPA  

 


 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, FC Global Realty Incorporated has duly caused this current report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 18, 2020

MARIZYME, INC.

 

 

 

 

By:

/s/ James Sapirstein

 

 

James Sapirstein

 

 

Interim Chief Executive Officer